GRNQ vs LICN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GRNQ exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic profit margin of -143.83%. While the stock has experienced a speculative price surge over the last year (+224.3%), this movement is completely decoupled from fundamentals, as revenue has plummeted by 53.50% YoY. With a Price-to-Sales ratio of 23.70 and no positive earnings to support a Graham Number or Intrinsic Value, the company is currently valued as a high-risk speculative vehicle rather than a viable business. The combination of shrinking top-line growth and deep operational losses suggests a precarious long-term outlook.
LICN presents as a classic value trap, characterized by a stable Piotroski F-Score of 5/9 but severe operational decay. While the balance sheet is exceptionally clean with negligible debt (D/E 0.01) and high liquidity (Current Ratio 10.19), the company is suffering from shrinking revenues (-21.2% YoY) and deep negative profit margins (-43.2%). The extreme Price-to-Book ratio of 0.04 suggests the market has almost entirely discounted the value of the company's assets due to poor earnings quality and a bearish technical trend.
Compare Another Pair
Related Comparisons
GRNQ vs LICN: Head-to-Head Comparison
This page compares Greenpro Capital Corp. (GRNQ) and Lichen International Limited (LICN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.